ly 274614 has been researched along with etorphine in 1 studies
Studies (ly 274614) | Trials (ly 274614) | Recent Studies (post-2010) (ly 274614) | Studies (etorphine) | Trials (etorphine) | Recent Studies (post-2010) (etorphine) |
---|---|---|---|---|---|
96 | 0 | 15 | 798 | 23 | 63 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, RM; Dykstra, LA | 1 |
1 other study(ies) available for ly 274614 and etorphine
Article | Year |
---|---|
Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cycloparaffins; Dose-Response Relationship, Drug; Drug Tolerance; Etorphine; Excitatory Amino Acid Antagonists; Isoquinolines; Male; Morphine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, mu; Tetrahydronaphthalenes | 2000 |